Jinyu bio-technology announced that its wholly-owned subsidiary Jinyu Baoling Biopharmaceutical Co., Ltd. has obtained a new veterinary drug registration certificate for the development of brucellosis live vaccine.
生物股份：子公司获布鲁氏菌病活疫苗新兽药注册证书
Jinyu bio-technology: Subsidiary obtained the new veterinary drug registration certificate for brucellosis live vaccine.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated